Francois Cedric
Apellis Pharmaceuticals, Inc. · Chief Executive Officer
Francois Cedric is listed in filings as Chief Executive Officer at Apellis Pharmaceuticals, Inc.. This profile follows SEC Form 4 activity through May 14, 2026, including sale activity. Recent filings connect the profile to Apellis Pharmaceuticals, Inc. (APLS). The current snapshot covers public activity from Jun 11, 2025 to May 14, 2026. Reported amounts are shown as $9.1M to $6.9M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $162k8.2k shares | SellJan 20, 2026 | $19.79 | $41.03 | |
| $226k10.2k shares | SellJan 13, 2026 | $22.19 | $41.03 | |
| $1M50k shares | SellAug 28, 2025 | $28.39 | $41.03 | |
| $5M175k shares | SellAug 27, 2025 | $28.19 | $41.03 | |
| $399k19.7k shares | SellJul 17, 2025 | $20.21 | $41.03 | |
| $38k1.9k shares | SellJul 15, 2025 | $20.09 | $41.03 | |
| $3M137.5k shares | SellJul 14, 2025 | $20.19 | $41.03 |